These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 30219977)

  • 21. Colchicine: an affordable anti-inflammatory agent for atherosclerosis.
    Thompson PL; Nidorf SM
    Curr Opin Lipidol; 2018 Dec; 29(6):467-473. PubMed ID: 30320614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond.
    Libby P
    J Am Coll Cardiol; 2017 Oct; 70(18):2278-2289. PubMed ID: 29073957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Critical roles of inflammation in atherosclerosis.
    Moriya J
    J Cardiol; 2019 Jan; 73(1):22-27. PubMed ID: 29907363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.
    Koenig W
    Int J Cardiol; 2013 Oct; 168(6):5126-34. PubMed ID: 23978367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Canakinumab for secondary prevention of atherosclerotic disease.
    Capodanno D; Angiolillo DJ
    Expert Opin Biol Ther; 2018 Feb; 18(2):215-220. PubMed ID: 29265905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on the Inflammatory Hypothesis of Coronary Artery Disease.
    Boland J; Long C
    Curr Cardiol Rep; 2021 Jan; 23(2):6. PubMed ID: 33409720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A functional interleukin-1 receptor antagonist polymorphism influences atherosclerosis development. The interleukin-1beta:interleukin-1 receptor antagonist balance in atherosclerosis.
    Olofsson PS; Sheikine Y; Jatta K; Ghaderi M; Samnegård A; Eriksson P; Sirsjö A
    Circ J; 2009 Aug; 73(8):1531-6. PubMed ID: 19574724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical implication and association between local and systemic levels of interleukin-1β and interleukin-10 in patients with coronary artery disease].
    Yan HB; Li WZ; Zhao HJ; Song L; Zheng B; Zhou P; Liu C
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Feb; 39(2):142-6. PubMed ID: 21426749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel anti-inflammatory therapies for the treatment of atherosclerosis.
    Khan R; Spagnoli V; Tardif JC; L'Allier PL
    Atherosclerosis; 2015 Jun; 240(2):497-509. PubMed ID: 25917947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A perspective on targeting inflammation and cytokine actions in atherosclerosis.
    Chan YH; Ramji DP
    Future Med Chem; 2020 Apr; 12(7):613-626. PubMed ID: 32175772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stage-dependent differential effects of interleukin-1 isoforms on experimental atherosclerosis.
    Vromman A; Ruvkun V; Shvartz E; Wojtkiewicz G; Santos Masson G; Tesmenitsky Y; Folco E; Gram H; Nahrendorf M; Swirski FK; Sukhova GK; Libby P
    Eur Heart J; 2019 Aug; 40(30):2482-2491. PubMed ID: 30698710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammation as a Therapeutic Target in Atherosclerosis.
    Nguyen MT; Fernando S; Schwarz N; Tan JT; Bursill CA; Psaltis PJ
    J Clin Med; 2019 Jul; 8(8):. PubMed ID: 31357404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice.
    Bhaskar V; Yin J; Mirza AM; Phan D; Vanegas S; Issafras H; Michelson K; Hunter JJ; Kantak SS
    Atherosclerosis; 2011 Jun; 216(2):313-20. PubMed ID: 21411094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statin Function as an Anti-inflammation Therapy for Depression in Patients With Coronary Artery Disease by Downregulating Interleukin-1β.
    Ma W; Shen D; Liu J; Pan J; Yu L; Shi W; Deng L; Zhu L; Yang F; Liu J; Cai W; Yang J; Luo Y; Cui H; Liu S
    J Cardiovasc Pharmacol; 2016 Feb; 67(2):129-35. PubMed ID: 26398164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inverse relationship between serum levels of interleukin-1beta and testosterone in men with stable coronary artery disease.
    Nettleship JE; Pugh PJ; Channer KS; Jones T; Jones RD
    Horm Metab Res; 2007 May; 39(5):366-71. PubMed ID: 17533579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of Colchicine in Acute Coronary Syndromes.
    Vaidya K; Martínez G; Patel S
    Clin Ther; 2019 Jan; 41(1):11-20. PubMed ID: 30185392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A positive feedback loop between IL-1β, LPS and NEU1 may promote atherosclerosis by enhancing a pro-inflammatory state in monocytes and macrophages.
    Sieve I; Ricke-Hoch M; Kasten M; Battmer K; Stapel B; Falk CS; Leisegang MS; Haverich A; Scherr M; Hilfiker-Kleiner D
    Vascul Pharmacol; 2018 Apr; 103-105():16-28. PubMed ID: 29371126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammation and atherosclerosis: a review of the role of interleukin-6 in the development of atherosclerosis and the potential for targeted drug therapy.
    Hartman J; Frishman WH
    Cardiol Rev; 2014; 22(3):147-51. PubMed ID: 24618929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new strategy for the treatment of atherothrombosis - inhibition of inflammation.
    Slíva J; Charalambous C; Bultas J; Karetová D
    Physiol Res; 2019 Nov; 68(Suppl 1):S17-S30. PubMed ID: 31755287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting interleukin-β by plant-derived natural products: Implications for the treatment of atherosclerotic cardiovascular disease.
    Vahdat-Lasemi F; Aghaee-Bakhtiari SH; Tasbandi A; Jaafari MR; Sahebkar A
    Phytother Res; 2021 Oct; 35(10):5596-5622. PubMed ID: 34390063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.